New CAR t-cell therapy takes on hard-to-treat leukemia
Disease control
Not yet recruiting
This study tests a new treatment called CCTx-001 for adults with acute myeloid leukemia (AML) that has come back or not responded to standard treatments. CCTx-001 is a type of immunotherapy that uses a patient's own immune cells, modified to target a protein called IL-1RAP found …
Phase: PHASE1, PHASE2 • Sponsor: Advesya SAS • Aim: Disease control
Last updated Jun 26, 2026 18:29 UTC